Radiobotics expands RBfracture capabilities for thoracic and lumbar spine fracture detection

Spine fracture detection further strengthens RBfracture’s role in supporting clinicians with accurate and timely fracture detection, particularly in emergency and trauma settings.

December 11, 2024 — Copenhagen, Denmark — Radiobotics, a leader in AI-driven musculoskeletal (MSK) radiology solutions, is proud to announce the expansion of its flagship product, RBfracture™, to include thoracic and lumbar spine fracture detection.

This enhancement further strengthens RBfracture’s role in supporting clinicians with accurate and timely fracture detection, particularly in emergency and trauma settings.

Both thoracic and lumbar spine fractures due to trauma can be caused by low-energy incidents, like falls, or high-energy traumas, like motor vehicle accidents.

“Most spinal fractures occur in the thoracic and lumbar spine,” says Pavel Lisouski, CTO and co-founder of Radiobotics. “The hospitals using our fracture detection for spine are typically ruling out injury in low-risk trauma patients.”

Feedback from one customer cited a low false positive rate, and that RBfracture identified a fracture of the right sided transverse process of L3, a fracture he might have otherwise missed.

“By incorporating thoracic and lumbar spine fracture detection, RBfracture now provides a more comprehensive workflow for emergency clinicians,” says Pavel.

Try RBfracture today at radiobotics.com/demo.

About Radiobotics

Founded in 2017, Radiobotics, a Medimaps Group company, is an award-winning Danish MedTech company dedicated to advancing musculoskeletal (MSK) radiology with AI-powered solutions. Radiobotics’ flagship solution, RBfracture™, is designed to support Emergency and Radiology with highly accurate detection of trauma-related findings, including fractures, dislocations, lipohemarthrosis, and effusion.

Radiobotics’ commitment to delivering precise, expert-level care in MSK imaging 24/7, regardless of time, infrastructure, or staffing constraints, constraints, is reflected in its close collaboration with leading clinical institutions, including partnering with Oxford University Hospital (OUH) on the world’s first and largest randomised clinical trial evaluating radiology AI in urgent care as well as achieving NICE approval for use in urgent care settings across the NHS.

Media contact
Elyse Sims
Head of Marketing, Radiobotics

Share this press release

Latest news